39777850|t|Mapping amyloid beta predictors of entorhinal tau in preclinical Alzheimer's disease.
39777850|a|INTRODUCTION: Amyloid beta (Abeta) plaques and hyperphosphorylated tau in the entorhinal regions are key Alzheimer's disease (AD) markers, but the spatial Abeta pathways influencing tau pathology remain unclear. METHODS: We applied predictive modeling to identify Abeta standardized uptake value ratio (SUVR) spatial patterns that predict entorhinal tau levels, future hippocampal volume, and Preclinical Alzheimer's Cognitive Composite (PACC) scores at 5-year follow-up. The model was trained on Alzheimer's Disease Neuroimaging Initiative (ADNI) (N = 237), incorporating amyloid-PET (positron emission tomography), tau-PET, magnetic resonance imaging (MRI), and cognitive data, and validated on Harvard Aging Brain Study (HABS) (N = 276). RESULTS: The model accurately predicted entorhinal tau levels (r = 0.48, p < 0.0001), future hippocampal volume (r = 0.24, p = 0.002), and PACC scores (r = 0.35, p < 0.0001) based on regional Abeta. DISCUSSION: Abeta in the rostral middle frontal, medial orbitofrontal, and striatal regions predict entorhinal tau levels, future hippocampal volume, and PACC scores, indicating their potential as early biomarkers in AD prediction models. HIGHLIGHTS: Positron emission tomography (PET) imaging reveals amyloid beta (Abeta) patterns predicting entorhinal tau levels in preclinical Alzheimer's disease (AD). Abeta in medial orbitofrontal, rostral middle frontal, and nucleus accumbens best predicts tau. Abeta distribution in these regions predicts future hippocampal neurodegeneration and cognitive decline. Model validated with Alzheimer's Disease Neuroimaging Initiative (ADNI) and Harvard Aging Brain Study (HABS) data sets, showing robustness and reproducibility. Findings suggest early Abeta patterns can aid in diagnosing AD and guide anti-Abeta therapies.
39777850	8	20	amyloid beta	Gene	351
39777850	46	49	tau	Gene	4137
39777850	65	84	Alzheimer's disease	Disease	MESH:D000544
39777850	100	112	Amyloid beta	Gene	351
39777850	114	119	Abeta	Gene	351
39777850	153	156	tau	Gene	4137
39777850	191	210	Alzheimer's disease	Disease	MESH:D000544
39777850	212	214	AD	Disease	MESH:D000544
39777850	241	246	Abeta	Gene	351
39777850	268	271	tau	Gene	4137
39777850	350	355	Abeta	Gene	351
39777850	436	439	tau	Gene	4137
39777850	491	502	Alzheimer's	Disease	MESH:D000544
39777850	583	602	Alzheimer's Disease	Disease	MESH:D000544
39777850	703	706	tau	Gene	4137
39777850	878	881	tau	Gene	4137
39777850	1019	1024	Abeta	Gene	351
39777850	1038	1043	Abeta	Gene	351
39777850	1137	1140	tau	Gene	4137
39777850	1243	1245	AD	Disease	MESH:D000544
39777850	1328	1340	amyloid beta	Gene	351
39777850	1342	1347	Abeta	Gene	351
39777850	1380	1383	tau	Gene	4137
39777850	1406	1425	Alzheimer's disease	Disease	MESH:D000544
39777850	1427	1429	AD	Disease	MESH:D000544
39777850	1432	1437	Abeta	Gene	351
39777850	1523	1526	tau	Gene	4137
39777850	1528	1533	Abeta	Gene	351
39777850	1592	1609	neurodegeneration	Disease	MESH:D019636
39777850	1614	1631	cognitive decline	Disease	MESH:D003072
39777850	1654	1673	Alzheimer's Disease	Disease	MESH:D000544
39777850	1816	1821	Abeta	Gene	351
39777850	1853	1855	AD	Disease	MESH:D000544
39777850	1871	1876	Abeta	Gene	351
39777850	Association	MESH:D000544	4137
39777850	Association	MESH:D003072	351
39777850	Association	351	4137
39777850	Association	MESH:D000544	351
39777850	Association	MESH:D019636	351

